Navigate Up

UPMC/University of Pittsburgh Schools of the Health Sciences
‚Äč
Patients and medical professionals may call 1-800-533-UPMC (8762) for more information.

UPMC Media Relations

Gene Therapy May Be A Cure For Post-Radical Prostatectomy Erectile Dysfunction, According To University Of Pittsburgh Research

CHICAGO, April 28, 2003 Researchers from the University of Pittsburgh Medical Center (UPMC) have found that gene therapy may not only be a feasible, but also may be an ideal treatment for neuropathic erectile dysfunction (ED). Neuropathic ED results from damage to the nerves essential to achieving and maintaining an erection and is experienced by 79.6 percent of men who undergo radical prostatectomies.

Results of the study were presented today at the annual meeting of the American Urological Association (AUA) and are published in abstract 1179 of the AUA proceedings.

While radical prostatectomy can be a cure for early stage prostate cancer in a large percentage of patients, there are a number of risks and side effects that patients must consider when deciding on whether to have the surgery or not one of those being the high likelihood of experiencing erectile dysfunction. said Michael Chancellor, M.D., director of neurourology at UPMC and professor of urology at the University of Pittsburgh School of Medicine. If by using gene therapy prior to surgery, we can minimize nerve damage and preserve the patients ability to have an erection, the patient may be less reluctant to have the potentially life-saving procedure.

In the study, researchers injected herpes simplex virus vectors that deliver neurotrophic factors, factors that facilitate the recovery of injured nerves, into the corpus cavernosum or cavernous nerve of rats at the time of cryo-injury to the cavernous nerve. The cavernous nerve is the nerve that stimulates erection; cryo-injury has similar effects on the nerve as radical prostatectomy. After injection, they found that the viral vectors transported the neurotrophic factors to the nerve. On electrical nerve stimulation, nerve-injured rats that expressed the viral vector experienced an increase in intracavernous pressure.

The researchers hope that this concept can be translated into humans, enabling gene therapy to be used as a prophylactic treatment for men undergoing radical prostatectomy.

Radical prostatectomy is used to treat the early stages of prostate cancer by surgically removing the prostate gland and surrounding tissue. The procedure has a success rate of 70 to 85 percent. A high percentage of patients experience ED after the procedure due to injury to the peripheral nerves, including the cavernous nerve, located close to the prostate gland.

In addition to studying the use of gene therapy to treat post-radical prostatectomy ED, the team from the University of Pittsburgh also is investigating the potential of using muscle derived stem cells to regenerate the peripheral nerves often damaged by radical prostatectomy. This study is published in abstract 1256 of the AUA proceedings.

©  UPMC | Affiliated with the University of Pittsburgh Schools of the Health Sciences
Supplemental content provided by A.D.A.M. Health Solutions. All rights reserved.

For help in finding a doctor or health service that suits your needs, call the UPMC Referral Service at 412-647-UPMC (8762) or 1-800-533-UPMC (8762). Select option 1.

UPMC is an equal opportunity employer. UPMC policy prohibits discrimination or harassment on the basis of race, color, religion, ancestry, national origin, age, sex, genetics, sexual orientation, marital status, familial status, disability, veteran status, or any other legally protected group status. Further, UPMC will continue to support and promote equal employment opportunity, human dignity, and racial, ethnic, and cultural diversity. This policy applies to admissions, employment, and access to and treatment in UPMC programs and activities. This commitment is made by UPMC in accordance with federal, state, and/or local laws and regulations.

Medical information made available on UPMC.com is not intended to be used as a substitute for professional medical advice, diagnosis, or treatment. You should not rely entirely on this information for your health care needs. Ask your own doctor or health care provider any specific medical questions that you have. Further, UPMC.com is not a tool to be used in the case of an emergency. If an emergency arises, you should seek appropriate emergency medical services.

For UPMC Mercy Patients: As a Catholic hospital, UPMC Mercy abides by the Ethical and Religious Directives for Catholic Health Care Services, as determined by the United States Conference of Catholic Bishops. As such, UPMC Mercy neither endorses nor provides medical practices and/or procedures that contradict the moral teachings of the Roman Catholic Church.

© UPMC
Pittsburgh, PA, USA UPMC.com